Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Compares the volatility characteristics of risk parity against index funds in retirement planning, highlighting stability and risk exposure.
27,630 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Canopy Growth sits at the center of sharp investor debate. This article maps three plausible paths for the stock over...
In the stock market today, june, chips rally on AI demand while big tech retreats on pricing. This deep dive breaks d...
Oil prices are climbing again as geopolitical risks and supply constraints threaten the global market. Analysts warn ...
A new wave of headlines around Nebius stock is stirring debate among investors. This guide breaks down what the news ...
Retail investors often wonder if congressional trades offer investing clues. This guide explains what "members congre...
Plug Power stock popped after-hours following a strong Q4 showing and raised 2026 guidance. This article breaks down ...
Walmart recently dropped out of the trillion-dollar club, leaving investors to wonder if the stock still deserves a p...
July can be a pivotal moment for travel stocks. Here are three clear reasons why Carnival stock may deserve a place o...
DraftKings is diversifying beyond its core betting business. This article examines what that shift could mean for inv...
In 1999, Mark Cuban reportedly earned more from hedging Yahoo shares with a protective collar than from selling Broad...
Jerash (JRSH) 2026 earnings could hinge on demand cycles, margin expansion, and stronger execution. This guide breaks...